Patent Early Warning Mechanism in Pharmaceutical Universities in China

亚洲社会药学

Patent Early Warning Mechanism in Pharmaceutical Universities in China

Jin Quanyuan1*, Lin Xiaohui1, Dong Li2

1.Science Research Department, Shenyang Pharmaceutical University, Shenyang 110016, China; 2.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

出版日期:2018-09-20 发布日期:2018-11-13

Patent Early Warning Mechanism in Pharmaceutical Universities in China

Jin Quanyuan1*, Lin Xiaohui1, Dong Li2

1.Science Research Department, Shenyang Pharmaceutical University, Shenyang 110016, China; 2.School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

Online:2018-09-20 Published:2018-11-13
Contact: Jin Quanyuan,Researcher. Major research area:science research management. Tel: 024-43520085, E-mail: sypukyc@163.net

摘要/Abstract

摘要： Objective To analyze the necessity of patent risk early warning mechanism in pharmaceutical universities, and to put forward some suggestions for making patent map for early warning. Methods Classification and function of patent map were analyzed to show that patent map played a vital role in information service for drug research and development of pharmaceutical universities. Results and Conclusion It is suggested pharmaceutical universities should improve their patent map mechanism to provide patent early warning for science research departments.

关键词: patent, early warning, patent map

Abstract: Objective To analyze the necessity of patent risk early warning mechanism in pharmaceutical universities, and to put forward some suggestions for making patent map for early warning. Methods Classification and function of patent map were analyzed to show that patent map played a vital role in information service for drug research and development of pharmaceutical universities. Results and Conclusion It is suggested pharmaceutical universities should improve their patent map mechanism to provide patent early warning for science research departments.

Key words: patent, early warning, patent map

Jin Quanyuan, Lin Xiaohui, Dong Li. Patent Early Warning Mechanism in Pharmaceutical Universities in China[J]. 亚洲社会药学.

Jin Quanyuan, Lin Xiaohui, Dong Li. Patent Early Warning Mechanism in Pharmaceutical Universities in China[J]. Asina Journal Of Social Pharmacy.

[1]	Yuan Hongmei, Zhang Wenfeng, Ma Junhong, Zeng Yingying, Meng Lingquan. Research on the Identification of Core Technologies of China’s Pharmaceutical Cold Chain Based on Patent Analysis[J]. 亚洲社会药学, 2021, 16(2): 128-138.
[2]	Wu Tong, Dong Li. Analysis on the Development Trend and Countermeasures of Clopidogrel [J]. 亚洲社会药学, 2021, 16(2): 139-144.
[3]	Ma Junhong, Zhang Wenfeng, Liu Yue, Yuan Hongmei, Zhang Dawei. Research on the Status Quo and Countermeasures of Patent Application in Liaoning Biopharmaceutical Industry Based on Patent Map[J]. 亚洲社会药学, 2021, 16(2): 145-153.
[4]	Wang Hongwei, Yang Yue. Research and Reference of the Authorized Generic Drug System in the US[J]. 亚洲社会药学, 2021, 16(1): 11-22.
[5]	Zhang Tianqi, Chen Yuwen. Research on the World’s Most Valuable Antihypertensive Drugs Based on Patent Analysis[J]. 亚洲社会药学, 2021, 16(1): 76-83.
[6]	Nie Zewen, Wang Ting, Yuan Hongmei. Analysis of Technological Opportunities in Liaoning Biopharmaceutical Industry from the Perspective of Innovation Subject[J]. 亚洲社会药学, 2020, 15(3): 126-138.
[7]	Zhang Wenfeng, Feng Xin, Yuan Hongmei. Research on Technology Opportunity Identification of Small and Medium-sized Vaccine Enterprises Based on Patent Analysis[J]. 亚洲社会药学, 2020, 15(2): 97-107.
[8]	Wu Yakun, Yuan Hongmei. Innovative Development of Bio-Pharmaceutical Industry in Liaoning Province from the Perspective of Patent Data[J]. 亚洲社会药学, 2019, 14(4): 174-184.
[9]	Zhao Zhe, Sheng Mengdi, Fan Junyan, Liu Yanwen, Dong Li. Patent Applications of Pharmaceutical Industry in Liaoning: Current Situation and Suggestions[J]. 亚洲社会药学, 2019, 14(4): 185-191.
[10]	Huang Yufeng, Luo Suping, Yuan Hongmei. Research on Drug-Patent Linkage System under the New Situation[J]. 亚洲社会药学, 2019, 14(1): 7-14.
[11]	Ding Wenqing, Luo Suping, Yuan Hongmei, Zhang Dawei. Research on Protection of the Interests of Generic Drug Companies in the Drug-Patent Linkage System Based on Cournot Model [J]. 亚洲社会药学, 2019, 14(1): 15-20.
[12]	Jin Quanyuan, Lin Xiaohui, Dong Li. Research on Setting up Patent Risk Management System in Medical colleges and universities in China[J]. 亚洲社会药学, 2018, 13(1): 8-15.
[13]	DING Lei;WEI Ying;CHEN Yan;YUAN Hong-mei*. Analysis of TCM Patented Technology Based onthe IPC Classification System[J]. , 2015, 10(4): 197-202.
[14]	LI Jun-li;WEN Qi;YU Pei-ming. Patent Status of Antidepressants: Duloxetine[J]. , 2014, 9(2): 87-91.
[15]	DONG Li;HUANG Tai-kang;;FU Ke-ling. Pharmaceutical Enterprises in China: Patent Infringement Risks and Management Strategies[J]. , 2014, 9(1): 22-24.

亚洲社会药学

Patent Early Warning Mechanism in Pharmaceutical Universities in China

Patent Early Warning Mechanism in Pharmaceutical Universities in China

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价